G6PD and malaria: Following this trial, a series of studies was planned to evaluate the safety and effectiveness of CD in operational settings in order to evaluate the extent to which the risks associated with the use of the drug in settings without G6PD screening might outweigh the benefits to malaria treatment [7] of which the present study conducted in 2004 was the only one to be completed.